1. Home
  2. AGEN vs ACR Comparison

AGEN vs ACR Comparison

Compare AGEN & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.23

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$18.67

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
ACR
Founded
1994
2005
Country
United States
United States
Employees
N/A
4
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
146.1M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
ACR
Price
$3.23
$18.67
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$14.50
$24.50
AVG Volume (30 Days)
672.7K
16.2K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
1.02
N/A
Revenue
$42,877,086.00
N/A
Revenue This Year
$107.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.33
$19.59
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$17.06
52 Week High
$7.34
$24.61

Technical Indicators

Market Signals
Indicator
AGEN
ACR
Relative Strength Index (RSI) 42.85 33.26
Support Level $2.93 $17.56
Resistance Level $3.26 $19.64
Average True Range (ATR) 0.22 0.58
MACD 0.01 -0.20
Stochastic Oscillator 36.93 4.58

Price Performance

Historical Comparison
AGEN
ACR

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: